These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 34781986)

  • 1. Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS.
    Lorente JA; Nin N; Villa P; Vasco D; Miguel-Coello AB; Rodriguez I; Herrero R; Peñuelas O; Ruiz-Cabello J; Izquierdo-Garcia JL
    Crit Care; 2021 Nov; 25(1):390. PubMed ID: 34781986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic Profile of ARDS by Nuclear Magnetic Resonance Spectroscopy in Patients With H1N1 Influenza Virus Pneumonia.
    Izquierdo-Garcia JL; Nin N; Jimenez-Clemente J; Horcajada JP; Arenas-Miras MDM; Gea J; Esteban A; Ruiz-Cabello J; Lorente JA
    Shock; 2018 Nov; 50(5):504-510. PubMed ID: 29293175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia.
    Lee CH; Banoei MM; Ansari M; Cheng MP; Lamontagne F; Griesdale D; Lasry DE; Demir K; Dhingra V; Tran KC; Lee T; Burns K; Sweet D; Marshall J; Slutsky A; Murthy S; Singer J; Patrick DM; Lee TC; Boyd JH; Walley KR; Fowler R; Haljan G; Vinh DC; Mcgeer A; Maslove D; Mann P; Donohoe K; Hernandez G; Rocheleau G; Trahtemberg U; Kumar A; Lou M; Dos Santos C; Baker A; Russell JA; Winston BW;
    Crit Care; 2024 Feb; 28(1):63. PubMed ID: 38414082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza-induced acute respiratory distress syndrome during the 2010-2016 seasons: bacterial co-infections and outcomes by virus type and subtype.
    Bal A; Casalegno JS; Melenotte C; Daviet F; Ninove L; Edouard S; Morfin F; Valette M; De Lamballerie X; Lina B; Papazian L; Nougairède A; Hraiech S
    Clin Microbiol Infect; 2020 Jul; 26(7):947.e1-947.e4. PubMed ID: 32205296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic signatures of acute respiratory distress syndrome: COVID versus non-COVID.
    Ji X; Ji HL
    Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L596-L603. PubMed ID: 38469648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza A (H1N1) vs non-H1N1 ARDS: analysis of clinical course.
    Töpfer L; Menk M; Weber-Carstens S; Spies C; Wernecke KD; Uhrig A; Lojewski C; Jörres A; Deja M
    J Crit Care; 2014 Jun; 29(3):340-6. PubMed ID: 24508203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study.
    Shi R; Lai C; Teboul JL; Dres M; Moretto F; De Vita N; Pham T; Bonny V; Mayaux J; Vaschetto R; Beurton A; Monnet X
    Crit Care; 2021 Jun; 25(1):186. PubMed ID: 34074313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminant biomarkers of acute respiratory distress syndrome associated to H1N1 influenza identified by metabolomics HPLC-QTOF-MS/MS platform.
    Ferrarini A; Righetti L; Martínez MP; Fernández-López M; Mastrangelo A; Horcajada JP; Betbesé A; Esteban A; Ordóñez J; Gea J; Cabello JR; Pellati F; Lorente JA; Nin N; Rupérez FJ
    Electrophoresis; 2017 Sep; 38(18):2341-2348. PubMed ID: 28714069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of pulmonary functions, exercise capacity, and quality of life after pulmonary rehabilitation in survivors of ARDS due to severe influenza A (H1N1) pneumonitis.
    Hsieh MJ; Lee WC; Cho HY; Wu MF; Hu HC; Kao KC; Chen NH; Tsai YH; Huang CC
    Influenza Other Respir Viruses; 2018 Sep; 12(5):643-648. PubMed ID: 29676537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute respiratory distress syndrome induced by a swine 2009 H1N1 variant in mice.
    Zhang Y; Sun H; Fan L; Ma Y; Sun Y; Pu J; Yang J; Qiao J; Ma G; Liu J
    PLoS One; 2012; 7(1):e29347. PubMed ID: 22235288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.
    Obi AT; Tignanelli CJ; Jacobs BN; Arya S; Park PK; Wakefield TW; Henke PK; Napolitano LM
    J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):317-324. PubMed ID: 30477976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of severe H1N1 pneumoniae: A retrospective study at intensive care units.
    Li SH; Hsieh MJ; Lin SW; Chuang LP; Lee CS; Chiu LC; Chang CH; Hu HC; Huang CC; Kao KC
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):26-33. PubMed ID: 30852002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review.
    Hariri LP; North CM; Shih AR; Israel RA; Maley JH; Villalba JA; Vinarsky V; Rubin J; Okin DA; Sclafani A; Alladina JW; Griffith JW; Gillette MA; Raz Y; Richards CJ; Wong AK; Ly A; Hung YP; Chivukula RR; Petri CR; Calhoun TF; Brenner LN; Hibbert KA; Medoff BD; Hardin CC; Stone JR; Mino-Kenudson M
    Chest; 2021 Jan; 159(1):73-84. PubMed ID: 33038391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum activin A and B, and follistatin in critically ill patients with influenza A(H1N1) infection.
    Linko R; Hedger MP; Pettilä V; Ruokonen E; Ala-Kokko T; Ludlow H; de Kretser DM
    BMC Infect Dis; 2014 May; 14():253. PubMed ID: 24885241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower airway microbiota compositions differ between influenza, COVID-19 and bacteria-related acute respiratory distress syndromes.
    Imbert S; Revers M; Enaud R; Orieux A; Camino A; Massri A; Villeneuve L; Carrié C; Petit L; Boyer A; Berger P; Gruson D; Delhaes L; Prével R
    Crit Care; 2024 Apr; 28(1):133. PubMed ID: 38649970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and pro-inflammatory mediators are associated with acute kidney injury in patients with A/H1N1 influenza and acute respiratory distress syndrome.
    Cruz-Lagunas A; Jiménez-Alvarez L; Ramírez G; Mendoza-Milla C; García-Sancho MC; Avila-Moreno F; Zamudio P; Urrea F; Ortiz-Quintero B; Campos-Toscuento VL; Morán J; Barrera AA; Martínez-Briseño D; Fernández-Plata R; Sierra-Vargas MP; Muñoz-Perea C; Illescas-Flores S; Bautista E; Suratt BT; Pérez-Padilla JR; Zuñiga J
    Exp Mol Pathol; 2014 Dec; 97(3):453-7. PubMed ID: 25305354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung protective strategy and prone ventilation resulting in successful outcome in a patient with ARDS due to H1N1.
    Sarkar D; Sarkar S; Anand S; Kapoor A
    BMJ Case Rep; 2011 Feb; 2011():. PubMed ID: 22707466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome caused by novel 2009 influenza A (H1N1) virus].
    Zhan QY; Sun B; Tong ZH; Guo LM; Xu L; Zhu X; Jia XJ; Wang C
    Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(46):3262-6. PubMed ID: 22333146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.
    ; Davies A; Jones D; Bailey M; Beca J; Bellomo R; Blackwell N; Forrest P; Gattas D; Granger E; Herkes R; Jackson A; McGuinness S; Nair P; Pellegrino V; Pettilä V; Plunkett B; Pye R; Torzillo P; Webb S; Wilson M; Ziegenfuss M
    JAMA; 2009 Nov; 302(17):1888-95. PubMed ID: 19822628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postexposure Liponucleotide Prophylaxis and Treatment Attenuates Acute Respiratory Distress Syndrome in Influenza-infected Mice.
    Rosas LE; Doolittle LM; Joseph LM; El-Musa H; Novotny MV; Hickman-Davis JM; Hite RD; Davis IC
    Am J Respir Cell Mol Biol; 2021 Jun; 64(6):677-686. PubMed ID: 33606602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.